- Home
- NWG vs KVUE Comparison
NWG vs KVUE Comparison
Compare NWG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWG
- KVUE
- Stock Information
- Founded
- NWG 1727
- KVUE 2022
- Country
- NWG United Kingdom
- KVUE United States
- Employees
- NWG N/A
- KVUE N/A
- Industry
- NWG Commercial Banks
- KVUE Specialty Chemicals
- Sector
- NWG Finance
- KVUE Consumer Discretionary
- Exchange
- NWG Nasdaq
- KVUE Nasdaq
- Market Cap
- NWG 47.5B
- KVUE 43.6B
- IPO Year
- NWG N/A
- KVUE 2023
- Fundamental
- Price
- NWG $11.97
- KVUE $23.69
- Analyst Decision
- NWG Strong Buy
- KVUE Buy
- Analyst Count
- NWG 1
- KVUE 14
- Target Price
- NWG N/A
- KVUE $24.00
- AVG Volume (30 Days)
- NWG 5.9M
- KVUE 15.5M
- Earning Date
- NWG 04-25-2025
- KVUE 05-06-2025
- Dividend Yield
- NWG 3.26%
- KVUE 3.46%
- EPS Growth
- NWG 11.25
- KVUE N/A
- EPS
- NWG 0.66
- KVUE 0.54
- Revenue
- NWG $17,957,609,819.00
- KVUE $15,455,000,000.00
- Revenue This Year
- NWG $12.14
- KVUE $1.55
- Revenue Next Year
- NWG $5.94
- KVUE $4.12
- P/E Ratio
- NWG $8.91
- KVUE $44.06
- Revenue Growth
- NWG 1.22
- KVUE 0.07
- 52 Week Low
- NWG $6.70
- KVUE $17.67
- 52 Week High
- NWG $12.65
- KVUE $24.46
- Technical
- Relative Strength Index (RSI)
- NWG 52.86
- KVUE 59.76
- Support Level
- NWG $11.98
- KVUE $22.80
- Resistance Level
- NWG $12.23
- KVUE $23.59
- Average True Range (ATR)
- NWG 0.20
- KVUE 0.50
- MACD
- NWG -0.04
- KVUE -0.04
- Stochastic Oscillator
- NWG 61.74
- KVUE 67.94
About NWG NatWest Group plc (each representing two (2))
NatWest Group derives around 90% of its total income from the United Kingdom. The bank operates a retail, commercial, and private bank in the U.K., offering clients lending and payment services as well as asset management services.
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.